These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 29229226)

  • 1. Cannabinoid Receptor Type II Ligands from Sandalwood Oil and Synthetic α-Santalol Derivatives.
    Paudel P; Pandey P; Paris JJ; Ashpole NM; Mahdi F; Tian JM; Lee J; Wang M; Xu M; Chittiboyina AG; Khan IA; Ross SA; Li XC
    J Nat Prod; 2023 Jul; 86(7):1786-1792. PubMed ID: 37450763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anomeric Answer to Sulfenamide Stability and α-Nucleophilicity.
    Wall BJ; VanVeller B
    J Org Chem; 2023 Nov; 88(21):15067-15072. PubMed ID: 37873923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Thiazole-Based SIRT2 Inhibitors Discovered via Molecular Modelling Studies and Enzymatic Assays.
    Abbotto E; Casini B; Piacente F; Scarano N; Cerri E; Tonelli M; Astigiano C; Millo E; Sturla L; Bruzzone S; Cichero E
    Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophore-based virtual screening from phytocannabinoids as antagonist r-CB1.
    Correia LC; Ferreira JV; de Lima HB; Silva GM; da Silva CHTP; de Molfetta FA; Hage-Melim LIS
    J Mol Model; 2022 Aug; 28(9):258. PubMed ID: 35978141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice.
    Ma H; Zhang G; Mou C; Fu X; Chen Y
    Front Pharmacol; 2018; 9():156. PubMed ID: 29615900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacology of cannabinoid receptors and their ligands: an overview.
    Pertwee RG
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligands.
    Penthala NR; Shoeib A; Dachavaram SS; Cabanlong CV; Yang J; Zhan CG; Prather PL; Crooks PA
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127501. PubMed ID: 32882418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands.
    Ragusa G; Bencivenni S; Morales P; Callaway T; Hurst DP; Asproni B; Merighi S; Loriga G; Pinna GA; Reggio PH; Gessi S; Murineddu G
    ChemMedChem; 2018 Jun; 13(11):1102-1114. PubMed ID: 29575721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing pyridazine-3-carboxamides to be CB2 agonists: The design, synthesis, structure-activity relationships and docking studies.
    Qian HY; Wang ZL; Xie XY; Pan YL; Li GJ; Xie X; Chen JZ
    Eur J Med Chem; 2017 Sep; 137():598-611. PubMed ID: 28651225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB
    Dore A; Asproni B; Scampuddu A; Gessi S; Murineddu G; Cichero E; Fossa P; Merighi S; Bencivenni S; Pinna GA
    Bioorg Med Chem; 2016 Nov; 24(21):5291-5301. PubMed ID: 27624523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking.
    Ragusa G; Gómez-Cañas M; Morales P; Rodríguez-Cueto C; Pazos MR; Asproni B; Cichero E; Fossa P; Pinna GA; Jagerovic N; Fernández-Ruiz J; Murineddu G
    Eur J Med Chem; 2017 Feb; 127():398-412. PubMed ID: 28088085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB
    Murineddu G; Deligia F; Ragusa G; García-Toscano L; Gómez-Cañas M; Asproni B; Satta V; Cichero E; Pazos R; Fossa P; Loriga G; Fernández-Ruiz J; Pinna GA
    Bioorg Med Chem; 2018 Jan; 26(1):295-307. PubMed ID: 29229226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective therapeutic agents for obesity: molecular modification approaches of centrally and peripherally acting selective cannabinoid 1 receptor antagonists.
    Sharma MK; Murumkar PR; Kanhed AM; Giridhar R; Yadav MR
    Eur J Med Chem; 2014 May; 79():298-339. PubMed ID: 24747288
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.